MATTHEW E MORROW MD NPI 1730160672

NPI Details

Matthew E Morrow, MD is a rheumatology internal medicine in Sandusky, OH with 35 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Matthew E Morrow, MD NPI is 1730160672. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1990

The provider's business location address is:

2500 W STRUB RD
BLDG 1, SUITE B
SANDUSKY, OH
ZIP 44870-390
Phone: (567) 998-3900
Fax: (567) 998-3899

The NPI 1730160672 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, ibandronate sodium, 1 mg (HCPCS:J1740)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of drug or substance into vein (HCPCS:96374)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Screening test for autoimmune disorder (HCPCS:86038)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Vitamin d-3 level (HCPCS:82306)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)

The enumeration date for this NPI number is 11/8/2005 and was last updated on 4/25/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.